Ipragliflozin Improves Hepatic Steatosis in Obese Mice and Liver Dysfunction in Type 2 Diabetic Patients Irrespective of Body Weight ReductionChikara Komiya, Yoshihiro Ogawa|PLoS ONE|2016Cited by 229
Macrophage-inducible C-type lectin underlies obesity-induced adipose tissue fibrosisMiyako Tanaka, Yoshihiro Ogawa|Nature Communications|2014Cited by 196
Canagliflozin, an SGLT2 inhibitor, attenuates the development of hepatocellular carcinoma in a mouse model of human NASHKumiko Shiba, Yoshihiro Ogawa|Scientific Reports|2018Cited by 174
Obeticholic acid protects against hepatocyte death and liver fibrosis in a murine model of nonalcoholic steatohepatitisToshihiro Goto, Yoshihiro Ogawa|Scientific Reports|2018Cited by 86
Antifibrotic effect of pirfenidone in a mouse model of human nonalcoholic steatohepatitisChikara Komiya, Yoshihiro Ogawa|Scientific Reports|2017Cited by 64